Insider · CIK 0001793412

Alam Kamran

Reports to the SEC for 2 companies · DALLAS, TX

sec.gov

Transactions

Companies

Filings

CIK

0001793412

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-04	TSHATaysha Gene Therapies, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−1,655 sh	$4.52	−$7,480.6	1,442,131
2026-01-26	TSHATaysha Gene Therapies, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−23.8K sh	$4.61	−$110K	1,443,786
2026-01-23	TSHATaysha Gene Therapies, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−79K sh	$4.75	−$375K	1,467,635
2026-01-12	TSHATaysha Gene Therapies, Inc.A Award	CHIEF FINANCIAL OFFICER	AAward	+359K sh	—	—	1,546,603
2026-01-12	TSHATaysha Gene Therapies, Inc. · Employee Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+231K sh	—	—	231,000
2025-08-21	TSHATaysha Gene Therapies, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−54.5K sh	$2.85	−$155K	1,187,603
2025-03-11	TSHATaysha Gene Therapies, Inc.F Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−29.8K sh	$1.69	−$50.4K	1,242,094
2025-01-02	TSHATaysha Gene Therapies, Inc. · Employee Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+431K sh	—	—	431,000
2025-01-02	TSHATaysha Gene Therapies, Inc.A Award	CHIEF FINANCIAL OFFICER	AAward	+431K sh	—	—	1,271,937
2024-02-02	TSHATaysha Gene Therapies, Inc.F Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−1,288 sh	$1.51	−$1,944.88	840,937
2024-01-02	TSHATaysha Gene Therapies, Inc. · Employee Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+590K sh	—	—	590,413
2024-01-02	TSHATaysha Gene Therapies, Inc.A Award	CHIEF FINANCIAL OFFICER	AAward	+590K sh	—	—	842,225
2023-12-14	TSHATaysha Gene Therapies, Inc. · Employee Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+188K sh	—	—	187,582
2023-08-24	TSHATaysha Gene Therapies, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−33K sh	$2.33	−$76.9K	258,042
2023-05-31	TSHATaysha Gene Therapies, Inc.A Award	CHIEF FINANCIAL OFFICER	AAward	+6,230 sh	—	—	291,042
2023-05-31	TSHATaysha Gene Therapies, Inc. · Employee Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+12.5K sh	—	—	12,462
2023-02-02	TSHATaysha Gene Therapies, Inc. · Employee Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+150K sh	—	—	149,900
2023-02-02	TSHATaysha Gene Therapies, Inc.A Award	CHIEF FINANCIAL OFFICER	AAward	+18.7K sh	—	—	284,812
2023-02-02	TSHATaysha Gene Therapies, Inc. · Employee Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+37.4K sh	—	—	37,384
2022-08-23	TSHATaysha Gene Therapies, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−3,325 sh	$3.47	−$11.5K	266,121
2022-08-22	TSHATaysha Gene Therapies, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−9,717 sh	$3.50	−$34K	269,446
2022-08-19	TSHATaysha Gene Therapies, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−11.5K sh	$3.75	−$43.1K	279,163
2022-08-18	TSHATaysha Gene Therapies, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−7,476 sh	$3.87	−$28.9K	290,645
2022-04-06	TSHATaysha Gene Therapies, Inc. · Employee Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+40K sh	—	—	40,000
2022-02-23	TSHATaysha Gene Therapies, Inc. · Employee Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+80K sh	—	—	80,000
2021-08-20	TSHATaysha Gene Therapies, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−2,094 sh	$17.14	−$35.9K	298,121
2021-08-20	TSHATaysha Gene Therapies, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−9,746 sh	$16.70	−$163K	300,215
2021-08-19	TSHATaysha Gene Therapies, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−9,354 sh	$16.43	−$154K	310,574
2021-08-19	TSHATaysha Gene Therapies, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−613 sh	$17.11	−$10.5K	309,961
2021-08-18	TSHATaysha Gene Therapies, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−11.2K sh	$17.35	−$194K	319,928
2021-01-19	TSHATaysha Gene Therapies, Inc. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+70K sh	—	—	70,000
2020-09-23	TSHATaysha Gene Therapies, Inc.A Award	CHIEF FINANCIAL OFFICER	AAward	+331K sh	—	—	331,121
2020-02-10	RCKTROCKET PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	SVP - Finance & PFO	AAward	+3,000 sh	—	—	3,000
2020-02-06	RCKTROCKET PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	SVP - Finance & PFO	AAward	+25K sh	—	—	25,000
2019-11-04	RCKTROCKET PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	SVP - Finance & PFO	AAward	+200K sh	—	—	200,000

Recent filings

Accepted (ET)
Feb 64
Alam Kamran0001793412-26-000012
SEC(opens sec.gov)
Jan 274
Alam Kamran0001793412-26-000008
SEC(opens sec.gov)
Jan 144
Alam Kamran0001793412-26-000002
SEC(opens sec.gov)
Aug 224
Alam Kamran0001415889-25-022749
SEC(opens sec.gov)
Apr 104/A
Alam Kamran0001415889-25-010539
SEC(opens sec.gov)
Mar 134
Alam Kamran0001415889-25-007997
SEC(opens sec.gov)
Jan 34
Alam Kamran0001415889-25-000595
SEC(opens sec.gov)
Feb 64
Alam Kamran0001415889-24-002809
SEC(opens sec.gov)
Jan 44
Alam Kamran0001209191-24-000811
SEC(opens sec.gov)
Dec 184
Alam Kamran0001209191-23-058977
SEC(opens sec.gov)
Aug 254
Alam Kamran0001209191-23-047323
SEC(opens sec.gov)
Jun 24
Alam Kamran0001209191-23-033681
SEC(opens sec.gov)
Feb 64
Alam Kamran0001209191-23-007396
SEC(opens sec.gov)
Aug 244
Alam Kamran0001209191-22-047353
SEC(opens sec.gov)

Companies

Address

C/O TAYSHA GENE THERAPIES, INC. 3000 PEGASUS PARK DRIVE, STE 1430

DALLAS, TX, 75247